Ready when it matters most
Autoimmune Medicines
Golden Hour Pharma provides access to advanced autoimmune medicines for healthcare institutions and specialist centres. Our portfolio covers biologics, DMARDs, and immunomodulators used across rheumatology, gastroenterology, dermatology, and neurology — sourced from WHO-GMP certified manufacturing facilities.
Autoimmune diseases affect millions globally, requiring long-term, carefully monitored therapy. We ensure consistent, compliant access to essential autoimmune medicines — especially in markets where reliable supply is most critical.
Autoimmune Medicine Portfolio
Comprehensive coverage across all major autoimmune therapeutic areas, sourced from internationally compliant facilities.
Rheumatology
Biologics and DMARDs for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and other inflammatory joint conditions.
Gastroenterology
Specialist medicines for inflammatory bowel disease including Crohn's disease and ulcerative colitis.
Neurology
Immunomodulatory therapies for multiple sclerosis and rare autoimmune neurological conditions.
Dermatology
Biologic and targeted therapies for psoriasis, atopic dermatitis, and other autoimmune skin conditions.
Nephrology & Rare Autoimmune Conditions
Specialist medicines for lupus nephritis, myasthenia gravis, and other systemic autoimmune disorders.
Transplant & Immunosuppression
Post-transplant immunosuppressive regimens and rejection management medicines.
Compliant Access to Critical Autoimmune Therapies
We support healthcare institutions, specialist centres, and government health programmes across MENA, Africa, Latin America, and global markets with consistent, compliant, and affordable access to advanced autoimmune medicines. Our focus is on markets where reliable pharmaceutical access is most critical.
Submit a Product Inquiry
For specific product availability, pricing, regulatory documentation, and delivery options — submit your inquiry with the product name, strength, required quantity, and destination country.